Navigation Links
AIDS Action Observes HIV Vaccine Awareness Day: Reason to Hope

WASHINGTON, May 18 /PRNewswire-USNewswire/ -- Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone. There are over 1.1 million people living with the virus in the United States. It is a disease that impacts minority and poor communities disproportionately: African-Americans are seven times more likely to contract HIV, while the rate of infection among Hispanics is three times that of whites. Amidst this tragic reality, the ongoing search for an HIV vaccine gives us reason to hope. The HIV vaccine research field continues to advance, and 2009 marks a year of promise. Today, on May 18th, HIV Vaccine Awareness Day, AIDS Action urges everyone to help end the AIDS epidemic by supporting HIV vaccine research. We also thank the numerous volunteers, community educators, scientists and advocates for their efforts to support HIV vaccine research.

The best long term hope for controlling the AIDS epidemic here and abroad is the development of safe, effective and affordable HIV vaccines. Historically, vaccines have been the most powerful weapon against diseases like polio, measles and Hepatitis B. In fact, no major viral epidemic has been defeated without one. HIV vaccine research is part of a robust HIV prevention research agenda, and integral to a sustainable comprehensive response to the epidemic.

While researchers have not yet found a vaccine, there are reasons to be hopeful. Several large scale efficacy trials in humans have already been completed. While their results did not yield an effective vaccine, they prompted innovative researchers to focus on basic science, leading to greater insight into human immunology. Using the lessons of the past, scientists are currently designing better clinical trials. And, there are promising candidates in the HIV vaccine pipeline. Results in the largest vaccine trial of 16,000 study participants in Thailand are expected in late 2009. There are several other candidates in clinical trials, and a new trial in the United States will soon begin. In this past year alone, six novel approaches being tested in monkeys have shown unprecedentedly positive initial findings. AIDS Action believes the horizon is bright.

This HIV Vaccine Awareness Day, we must remind ourselves that a life-saving HIV vaccine is possible. To be sure, it will require our best scientific minds. It will also rely on commitment from our political leaders and global investment, as well as support from ordinary citizens. AIDS Action is committed to advocating for continued political commitment and optimizing the environment for HIV vaccine research through education and awareness building. Through its membership network of AIDS service organizations, health departments, health educators and community-based organizations across the country, AIDS Action is working to establish leadership and increase HIV vaccine awareness among key influencers and community and national leaders.

But we can't do it alone. We need your help. Stay informed. Learn about HIV vaccine research efforts, talk about HIV vaccine research with your family and friends, support a trial volunteer, contact your local trial site to become a volunteer or join a community advisory board. We encourage everyone to become involved in HIV Vaccine Awareness Day.

Learn more about events in your area, how you can help, and the facts about HIV vaccine research at and

AIDS Action strives to end the HIV epidemic by advancing public policies that prevent new infections, provide care for people living with HIV and support the search for a cure. AIDS Action serves as the national voice for AIDS service organizations, health departments and a diverse network of community-based organizations across the country that provide services for people living with or affected by HIV infection.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mitchell and Jopari Say Green Transaction Initiatives Play Key Role in P&C and Group Health Industry Environmental Best Practices
2. OpenViBE: The first French software program enabling action through thought
3. Physician practice interactions with health plans cost $31 billion a year
4. Dr. Peter J. Capizzi of Stillwater Plastic Surgery Honored in Patient Satisfaction Survey
5. CriticalPoint(TM) Training Rated Excellent in Customer Satisfaction
6. Breast Cancer Action Sues to End Gene Patenting
7. Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
8. A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier
9. AIDS Action Welcomes Presidents Budget Increases Yet Expresses Distress With Failure to End Federal Ban on Syringe Exchange Funding
10. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
11. Polls Show Americans Concerned About Swine Flu, Taking Actions to Protect Themselves
Post Your Comments:
(Date:11/30/2015)... Fla. (PRWEB) , ... November 30, 2015 , ... ... opened the driverless vehicle experience this summer, ushering in a new era of ... percent driverless and electric shuttle, will continue to offer guests an up-close look ...
(Date:11/30/2015)... ... 30, 2015 , ... The presidential race normally deals with political issues of ... a national news story when Donald Trump makes disparaging remarks about Hillary Clinton’s hairstyle? ... than anyone wants to admit when it comes to how people are viewed by ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... continuing education course in Dallas, TX, on January 29 and 30, 2016. The ... improve the functions of their practices, to learn how to better succeed in ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one ... , Their study showed that small molecule analogs that target the functions of ...
(Date:11/30/2015)... ... 30, 2015 , ... Dr. Seth D. Margulies specializes in orthodontics and is ... Margulies to experience the best available orthodontic experience in the area. Dr. Margulies ... , Orthodontics is the branch of dentistry that specializes in the diagnosis, prevention, and ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... -- IBA Molecular North America, Inc. (IBAMNA), a U.S. leader ... as of January 1, 2016, it will do business ... rebrand the company reflects a refined vision for the ... relationship with Zevacor Molecular.  Both IBAMNA and Zevacor Molecular ... Peter Burke , Vice President Sales and ...
(Date:11/30/2015)... -- North America was valued at ... a CAGR of 7.6% from 2015 to 2020. --> ... in 2014, and is expected to grow at a CAGR of ... new Market Research Report "North America Cardiac Output Monitoring Devices Market ... care, others) - Analysis And Forecast To 2020", the cardiac output ...
(Date:11/30/2015)... , Nov. 30, 2015  Kevin Smith ... Sensium Healthcare, a global pioneer in wireless monitoring ... Boston, MA , Mr. Smith will ... Sensium,s global commercial strategy.  He will also directly ... to build clinical evidence for SensiumVitals, the first ...
Breaking Medicine Technology: